Johnson & Johnson NYSE:JNJ

142.89 0.83500000000001 (0.024962341295459)
(2017-11-01 13:45:00)

Popular
Last: 142.89
Change: 0.83500000000001
Change %: 0.024962341295459
Volume: 2117124
Estimated Turnover: 295000058.16
MC: 383876849945
EPS: 5.949
P/E: 23.574550344596
P/B: 5.3731657790889
P/S: 5.06
Dividend Yield %: 0.0239580733716
52w High: 144.352
52w Low: 109.32
ROI: 0.1313
ROA: 0.1069
ROE: 0.2157
ROIC: 0.18718500969201

Price
Last: 142.89
Change: 0.83500000000001
Change %: 0.024962341295459
Volume: 2117124
Open: 139.83
High: 140.59
Low: 139.34
Prev: 139.41
52w High Change%: -0.010128020394591
52w Low Change%: 0.30708013172338
Volume Avg (10d): 6329836
Volume Avg (3m): 5627862
Volume Avg: 6183894
Turnover Avg (10d): 896603451
Turnover Avg (3m): 780937022
Turnover Avg: 212724490
LR Change % (1y): -0.04
LR Change % (3y): 0.66
LR Change % (5y): 0.61
LR Change % (10y): 0.68
LR Change % (15y): 0.92
5SMA: 141.0719996
10SMA: 141.5739972
20SMA: 138.4604971
50SMA: 134.58898154
100SMA: 133.49030467
200SMA: 127.29275805
250SMA: 124.358030132
Price Cross 5SMA: 0.012887039278913
Price Cross 10SMA: 0.0092955120716194
Price Cross 20SMA: 0.031991094881025
Price Cross 50SMA: 0.06167680567174
Price Cross 100SMA : 0.070414816665801
Price Cross 200SMA: 0.12253047375934
Price Cross 250SMA: 0.14902109536738
5 Cross 20 SMA: 0.018860993241371
10 Cross 50 SMA: 0.051898867054909
50 Cross 100 SMA: 0.0082303870136191
50 Cross 200 SMA: 0.057318449232862
50 Cross 250 SMA: 0.057318449232862

Valuation
MC: 383876849945
P/E: 23.574550344596
Forward P/E: 17.499348
P/E high (5y): 19.43
P/E low (5y): 18.01
PEG: 2.92
P/B: 5.3731657790889
Book Value Per Share: 26.101
P/S: 5.06
Sales Per Share: 27.784584980237
Price/Cash: 9.3496666666667
Price/Free Cashflow: 27.206884587907
Earnings Yield: 0.042418624549895

Profitability
EPS: 5.949
Forward EPS: 7.67
ROI: 0.1313
ROI (5y): 0.14
ROA: 0.1069
ROA (5y): 0.1124
ROE: 0.2157
ROE (5y): 0.2124
ROIC: 0.18718500969201
Profit Margin: 0.22868
Gross Margin: 0.6829
Gross Margin Avg (5y): 0.6924
Operating Margin: 0.2614
Operating Margin Avg (5y): 0.2503
EBITD Margin: 0.3614
EBITD Margin Avg (5y): 0.3331
Profit Margin: 0.2128
Profit Margin Avg (5y): 0.2047

Growth
EPS Growth: 0.013
EPS Growth (q): -0.008
EPS Growth (5y): 0.1122
Revenue Growth: 0.016
Sales Growth (5y): 0.0203
Dividend Growth (5y): 0.0696

Fundamental
Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers - Major
Country: United States
Employees: 126400
Floating Shares: 2692647721
Outstanding Shares: 2686520050
Shares Short: 17754100
Shares Short (prior month): 16772400
Held by Insiders %: 0.00017999999
Held by Institutions %: 0.67300004
Short Ratio: 2.31
Short Float %: 0.006551
Beta: 0.681819
RPS: 26.489
Net Income to Common: 16504999936
Total Cash: 39351001088
Cash Per Share: 15
EBITDA: 25120000000
Total Debt: 32714999808
Quick Ratio: 1.02
Current Ratio: 1.32
Total Revenue: 72174002176
Debt / Equity: 0.4754
LT Debt / Equity: 0.3606
Gross Profits: 50205000000
Free Cashflow: 13835374592
Operating Cash Flow: 19491000320
Ebitda Margin: 0.34805
stock.nopat: 17382000000
Dividend/ Share: 3.36
Dividend % Avg (5y): 0.0286
Free Cashflow / Share: 5.1547614555743
Long Term Debt: 22442000000
Shareholder Equity: 70418000000
Total Capital: 92860000000
Payout: 55.8
Interest Coverage: 85.45